Education

Lawmakers cut CME exemption from 21st Century Cures Act

Lawmakers cut CME exemption from 21st Century Cures Act

The bill includes provisions to investigate the usefulness of off-label information but will no longer exempt drugmakers from reporting CME payments.

Best Disease Education Campaign of 2016

Best Disease Education Campaign of 2016

Rather than overtly push product information to already-stressed parents, 2e Creative and Alcon created Muck, a gorgeous glossy magazine available alongside other magazines in pediatricians' waiting rooms.

Lewis Miller on the Evolving CME Landscape

Lewis Miller on the Evolving CME Landscape

Rising healthcare costs, the need for team health delivery and enhanced teamwork, and empowered consumers have all played a role.

5 Ways to Improve the Customer Experience for Oncologists

5 Ways to Improve the Customer Experience for Oncologists

One critical aspect of oncology drugmakers' business remains firmly rooted in the past. That's customer experience.

Five things for pharma marketers to know: Wednesday, August 10, 2016

Five things for pharma marketers to know: Wednesday, August 10, 2016

A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion

Finding a Better Strategy for Pricing Drugs

Finding a Better Strategy for Pricing Drugs

We need to consider that not every expenditure is beneficial to patients: perhaps that Super Bowl commercial or that sales meeting in Maui may not be in their best interest.

ACCME, PharmedOut spar over CME money

ACCME, PharmedOut spar over CME money

The main accreditation body for CME activities traded barbs with an academic critic over courses designed to enlighten doctors about hypoactive sexual desire disorder.

Exploring the Opportunity For Halal In Healthcare

Exploring the Opportunity For Halal In Healthcare

There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.

Five things for pharma marketers to know: Tuesday, July 21

Five things for pharma marketers to know: Tuesday, July 21

Physicians criticize pricing of Orkambi, Vertex's new cystic-fibrosis drug; the EU approves Amgen's PCSK9 inhibitor Repatha; PhRMA boosts lobbying spending in the second quarter

CMS updates CME guidance

CMS updates CME guidance

New rules will require manufacturers to report some indirect payments made to physicians for CME activities.